Utilisation trend of long-acting insulin analogues including biosimilars across Europe: findings and implications

Brian Godman, Magdalene Wladysiuk, Stuart McTaggart, Amanj Kurdi, Eleonora Allocati, Mihajlo Jakovljevic, Francis Kalemeera, Iris Hoxha, Anna Nachtnebel, Robert Sauermann, Manfred Hinteregger, Vanda Marković-Peković, Biljana Tubić, Guenka Petrova, Konstantin Tachkov, Juraj Slabý, Radka Nejezchlebova, Iva Selke Krulichová, Ott Laius, Gisbert SelkeIrene Langner, András Harsanyi, Andras Inotai, Arianit Jakupi, Svens Henkuzens, Kristina Garuolienė, Jolanta Gulbinovic, Patricia Vella Bonanno, Jakub Rutkowski, Skule Ingeberg, Oyvind Melien, Ileana Mardare, Jurij Fürst, Sean MacBride-Stewart, Carol Holmes, Caridad Pontes, Corinne Zara, Marta Turu Pedrola, Mikael Hoffmann, Vasileios Kourafalos, Alice Pisana, Rita Banzi, Stephen M. Campbell, Bjorn Wettermark

Research output: Contribution to journalArticlepeer-review

1 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Utilisation trend of long-acting insulin analogues including biosimilars across Europe: findings and implications'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds